-
Role of interventional endoscopic ultrasound in a developing country
-
Hasan Maulahela, Nagita Gianty Annisa, Achmad Fauzi, Kaka Renaldi, Murdani Abdullah, Marcellus Simadibrata, Dadang Makmun, Ari Fahrial Syam
-
Clin Endosc 2023;56(1):100-106. Published online January 17, 2023
-
DOI: https://doi.org/10.5946/ce.2022.058
-
-
Abstract
PDF PubReader ePub
- Background
/Aims: Endoscopic ultrasound (EUS) has become an essential diagnostic and therapeutic tool. EUS was introduced in 2013 in Indonesia and is considered relatively new. This study aimed to describe the current role of interventional EUS at our hospital as a part of the Indonesian tertiary health center experience.
Methods This retrospective study included all patients who underwent interventional EUS (n=94) at our center between January 2015 and December 2020. Patient characteristics, technical success, clinical success, and adverse events associated with each type of interventional EUS procedure were evaluated.
Results Altogether, 94 interventional EUS procedures were performed at our center between 2015 and 2020 including 75 cases of EUS-guided biliary drainage (EUS-BD), 14 cases of EUS-guided pancreatic fluid drainage, and five cases of EUS-guided celiac plexus neurolysis. The technical and clinical success rates of EUS-BD were 98.6% and 52%, respectively. The technical success rate was 100% for both EUS-guided pancreatic fluid drainage and EUS-guided celiac plexus neurolysis. The adverse event rates were 10.6% and 7.1% for EUS-BD and EUS-guided pancreatic fluid drainage, respectively.
Conclusions EUS is an effective and safe tool for the treatment of gastrointestinal and biliary diseases. It has a low rate of adverse events, even in developing countries.
-
Citations
Citations to this article as recorded by 
- EUS-guided interventional therapies for pancreatic diseases
Rongmin Xu, Kai Zhang, Nan Ge, Siyu Sun Frontiers in Medicine.2024;[Epub] CrossRef
-
3,320
View
-
175
Download
-
1
Web of Science
-
1
Crossref
-
Clinical Practice of Gastrointestinal Endoscopy in COVID-19 Patients: An Experience from Indonesia
-
Rabbinu Rangga Pribadi, Amanda Pitarini Utari, Virly Nanda Muzellina, Saskia Aziza Nursyirwan, Hasan Maulahela, Kaka Renaldi, Ari Fahrial Syam
-
Clin Endosc 2022;55(1):156-159. Published online July 20, 2021
-
DOI: https://doi.org/10.5946/ce.2021.088
-
-
PDF PubReader ePub
-
Citations
Citations to this article as recorded by 
- Gastrointestinal Endoscopy and Coronavirus Disease-2019 Pandemic
Darmadi Darmadi, Cennikon Pakpahan, Riska Habriel Ruslie Open Access Macedonian Journal of Medical Sciences.2022; 10(F): 81. CrossRef - Correspondence on “Clinical practice of gastrointestinal endoscopy in COVID-19 patients: an experience from Indonesia”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit Clinical Endoscopy.2022; 55(4): 579. CrossRef
-
4,989
View
-
204
Download
-
1
Web of Science
-
2
Crossref
-
Best practice of gastrointestinal endoscopy during Mpox upsurge: an Indonesian Society for Digestive Endoscopy recommendation
-
Rabbinu Rangga Pribadi, Ahmad Fariz Malvi Zamzam Zein, Raisa Wibowo, Achmad Fauzi, Abdul Aziz Rani, Marcellus Simadibrata, Dadang Makmun, Murdani Abdullah, Ari Fahrial Syam, Muhammad Miftahussurur, Agasjtya Wisjnu Wardhana, Amanda Pitarini Utari, Andi Muhammad Luthfi Parewangi, Arles Arles, Arnelis Arnelis, Bradley Jimmy Waleleng, Bogi Pratomo Wibowo, Fauzi Yusuf, Hasan Maulahela, Hery Djagat Purnomo, I Dewa Nyoman Wibawa, Ignatia Sinta Murti, Indra Marki, Kaka Renaldi, Masrul Lubis, Muhammad Begawan Bestari, Muhammad Firhat Idrus, Pieter Saragih, Putut Bayupurnama, Ruswhandi Ruswhandi, Saskia Aziza Nursyirwan, Suyata Suyata, Titong Sugihartono, Triyanta Yuli Pramana, Virly Nanda Muzellina, Yustar Mulyadi, on behalf of the Indonesian Society for Digestive Endoscopy
-
Received November 4, 2024 Accepted February 7, 2025 Published online March 19, 2025
-
DOI: https://doi.org/10.5946/ce.2024.294
-
-
Abstract
PubReader ePub
- The emergence of Mpox as a significant zoonotic viral threat presents new challenges in gastrointestinal endoscopy. This article outlines the risk of Mpox transmission during gastrointestinal endoscopy, particularly through respiratory droplets and contact with the mucosal surfaces. Gastrointestinal endoscopy may also facilitate transmission by fomites, as the Mpox virus can persist on medical instruments and surfaces for long periods. Nosocomial Mpox transmission is a significant concern in both endemic and non-endemic regions. This highlights the necessity for enhanced infection control measures in gastrointestinal endoscopy, including pre-endoscopic assessment, proper use of personal protective equipment, and rigorous post-procedural disinfection. Additionally, vaccination of healthcare workers frequently exposed to high-risk situations is emphasized. Ongoing surveillance and monitoring of healthcare workers are key components in minimizing the transmission risk. Although no direct cases of Mpox transmission via gastrointestinal endoscopy have been reported, these recommendations mitigate the potential risks associated with such procedures and necessitate strict adherence to infection control protocols. By adhering to these protocols and adapting to current practices, gastrointestinal endoscopy can be safely performed during the Mpox upsurge, ensuring the protection of both patients and healthcare workers.
|